CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Trastuzumab plus docetaxel and capecitabine for first-line treatment of Her2-positive advanced gastric cancer: A phase II, multi-center, open-label, singlearm study. 会议论文
作者:  Wang, Feng;  Liu, Tian Shu;  Yuan, Xianglin;  Gu, Kangsheng;  Yuan, Ying
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial. 会议论文
作者:  Qin, Shukui;  Kim, Tae Won;  Yau, Thomas Cheung;  Ma, Brigette;  Pan, Hongming
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/19
A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer 会议论文
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Keming;  Wu, Gang;  Shi, Chunmei
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/19
The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries 会议论文
作者:  Sun, Guo-ping;  Sun, Yan;  Xu, Rui-hua;  Xu, Jian-Ming;  Li, Jin
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace